Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy by Randall E. HarrisInflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy by Randall E. Harris

Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy

EditorRandall E. Harris

Paperback | November 22, 2010

Pricing and Purchase Info

$377.80 online 
$388.95 list price
Earn 1,889 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


In "Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy", a worldwide panel of leading experts discusses the role of inflammation in the pathogenesis of major chronic diseases and the current controversy regarding risk versus benefit of selective cyclooxygenase-2 (COX-2) inhibitors. This volume is intended for scientists in medicine, epidemiology, pharmacology, molecular biology, and related fields. The authors provide exciting and enlightening perspectives on COX-2 and related molecular targets in the future of medicine, including historical perspectives on the discovery and development of aspirin, ibuprofen, and compounds that selectively inhibit COX-2, and the potential for development of new compounds with better efficacy and safety in the 21st century. Specfic chapters illuminate the role of inflammatory mechanisms in the pathogenesis of arthritis, cardiovascular disease, cancer, neurodegenerative disease, diabetes mellitus, obesity, and other life-threatening and debilitating conditions. Experts in cardiovascular medicine explore the "COX-2 controversy" regarding adverse effects of some (not all) selective COX-2 inhibitors on the cardiovasculature. Recent findings suggest that cardiovascular risk associated with some COX-2 inhibitors may not be due to a class effect, but rather depends upon the molecular structure of specific compounds. Important findings are documented in cancer research showing that selective COX-2 inhibitors have powerful antineoplastic effects against major forms of cancer. A special section explores the current evidence supporting the role of COX-2 and inflammation in the development of Alzheimer's disease and other neurodegenerative conditions and the potential benefit of compounds that modulate COX-2 and other inflammatory cytokines. The final section addresses nutritional modulation of inflammation and the chemopreventive value of anti-inflammatory nutraceutical agents.
Title:Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 ControversyFormat:PaperbackDimensions:338 pages, 9.25 × 6.1 × 0 inPublished:November 22, 2010Publisher:Springer NetherlandsLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9048174295

ISBN - 13:9789048174294

Look for similar items by category:


Table of Contents

PrefaceContributorsI. Historical PerspectivesCHAPTER 1. Anti-inflammatory Drugs in the 21st Century K. D. Rainsford, PhDII. Inflammatory Mechanisms of Pathogenesis CHAPTER 2. Nitric oxide synthase and cyclooxygenase interactions in cartilage and meniscus: relationships to joint physiology, arthritis, and tissue repairJ. Brice Weinberg, MD, Beverley Fermor, PhD, Farshid Guilak, PhD CHAPTER 3. obesity, inflammation, and vascular disease: The Role of the Adipose Tissue as an Endocrine OrganPaolo Calabro', MD, Edward T. H. Yeh, MDChapter 4. COX-2 and THE Inflammogenesis of Cancer Randall E. Harris, MD, PhDCHAPTER 5. Role of COX-2 in Inflammatory AND DEGENERATIVE Brain DiseasesLuisa Minghetti, PhDIII. Inflammation and Cardiovascular Disease: the Coxib ControversyCHAPTER 6. Cardiovascular Effects of the Selective Cyclooxygenase-2 InhibitorsWilliam B. White, MDCHAPTER 7. COX-2 inhibitors and Cardiovascular RiskDaniel J. Salzberg, MD, Matthew R. Weir, MDCHAPTER 8. A BIOLOGICAL RATIONALE FOR THE CARDIOTOXIC EFFECTS OF ROFECOXIB: COMPARATIVE Analysis with other COX-2 Selective Agents and NSAIDsR. Preston Mason, PhD, Mary F. Walter, PhD, Charles A. Day, Robert F. Jacob, PhDIV. COX-2 Blockade in Cancer Prevention and TherapyCHAPTER 9. Cancer Chemoprevention by COX-2 Blockade: Results of Case Control Studies. Randall E. Harris, MD, PhD, Joanne Beebe-Donk, Galal A. Alshafie, MD, PhDCHAPTER 10. Strategies for Colon Cancer Prevention:Combination of Chemopreventive AgentsBandaru S. Reddy, DVM, PhDV. Inflammation and Neurodegenerative DiseaseCHAPTER 11. NSAIDs FOR THE Chemoprevention of Alzheimer's Disease Christine A. Szekely, Ph.D., Terrence Town, Ph.D, Peter P. Zandi, Ph.DCHAPTER 12. Inflammation in Parkinson's disease: causative or epiphenomenal?Andreas Hald, PhD, Johan van Beek, PhD, and Julie Lotharius, PhDVI. Nutrition, Inflammation and Chronic Disease CHAPTER 13. NUTRITION, INFLAMMATION, AND CARDIOVASCULAR DISEASE Michel de Logeril, MDCHAPTER 14. NUTRITION, INFLAMMATION & bRAIN AGINGFrances C. Lau, PhD, Barbara Shukitt-Hale, PhD, James Joseph, PhDINDEX

Editorial Reviews

From the reviews:"This is an up-to-date review of the current understanding of inflammation, the mechanisms by which it affects disease, and the role of anti-inflammatory medications pertaining to COX-2 and its inhibition. . Physicians and researchers with a particular interest in the current research and understanding of inflammation and COX-2 inhibition are the intended readers. . It is detailed, but written with great clarity and exhaustive references. It will be a great addition to any medical library." (Vladimir N. Despotovic, Doody's Review Service, February, 2010)